VieCure celebrates the grand opening of the Dr. Don Iverson Center for Oncology Innovation

DENVER–(BUSINESS WIRE)–VieCure, a cancer care company with a market-leading artificial intelligence, informatics and clinical decision support platform, today announced the opening of the Dr. Don Iverson Oncology Innovation Center. The Iverson Innovation Center is designed to simulate, for oncologists and thought leaders in cancer care, the experience of treating patients in the emerging new era of precision oncology. In recent years, there has been a big shift towards the use of cancer treatments that specifically respond to the molecular profile of cancer (eg, genomic data). These data are complex, extensive and difficult to access at the community oncology level. Next-generation sequencing (NGS) assays to identify genomic drivers of a patient’s cancer are now fundamental to precision oncology, with rapidly expanding diagnostic, prognostic and therapeutic implications. Although few question the importance of NGS in modern cancer care, the process of collecting primary molecular data, integrating it into the patient’s electronic health record, and using it optimally to aid in patient treatment decisions and as part of a clinical workflow remains far from transparent. Many challenges persist around data standards and interoperability, and clinicians often face difficulties managing the growing amount of genomic knowledge needed to care for patients and keep up to date.

There is also a critical absence of medical guidance for providers and payers, which ultimately motivated the launch of VieCure in 2015 to build and deploy a next-generation AI-enabled clinical decision support platform. in oncology, with the ability to translate reams of complex treatment considerations into usable information at the fingertips of busy providers.

“Cancer centers across the United States are moving away from reliance on the traditional use of chemotherapy, radiation therapy, and cancer surgery and favor sequencing patients at the time of diagnosis and then applying of AI to generate personalized treatment plans that often incorporate the latest immunotherapies and targeted therapies,” said Dr. Fred Ashbury, Chief Scientific Officer of VieCure. “Generating these complex personalized treatment plans requires the use of new clinical decision support technology, such as the VieCure™ platform, and requires clinical workflow changes. Therefore, we created the Iverson Innovation Center – to simulate this new patient experience and to help cancer care providers and managers accelerate their adoption of precision medicine.

The Dr. Don Iverson Center for Oncology Innovation simulates the patient experience from the moment of diagnosis, through treatment plan review and selection, to patient-specific prescription generation, l action of this prescription in the context of infusion, follow-up care, cost entry, billing, planning, etc.

Building on the strong intersection of technology and healthcare industries in Colorado, VieCure continues to recruit professionals in the Denver market. “VieCure employs a growing number of software engineers, cancer care workflow professionals, quality assurance and clinical content professionals, oncology business development experts, and data leaders and analytics,” said Gerry Hogue, President and CEO of VieCure. “The company selected Denver and specifically the Tech Center a few years ago and is now opening its new, expanded space in Greenwood Village.”

The company now organizes visits from customers and partners. Oncologists, Cancer Care CEOs, and executives from pharmaceutical and molecular diagnostics companies are at the Iverson Innovation Center today, learning about the cancer patient journey reimagined through the use of technologies from VieCure.

About VieCure

VieCure has developed a proprietary artificial intelligence computing software platform in conjunction with a clinical inference engine and oncology point-of-care decision support system. The VieCure™ platform combines the latest clinical insights with patient data to help clinicians generate personalized treatment plans and better manage a patient’s treatment throughout diagnosis, cancer treatment and follow-up care continuous. VieCure was launched in 2015 and has contracts with leading community cancer centers like the American Oncology Network, with practices nationwide, Alabama Cancer Care (Tuscaloosa, Alabama), Clermont Oncology (Clermont, Fla. ) and many others. VieCure’s network of contract cancer centers now includes more than 100 sites in the United States. For more information, please visit viecure.com and connect with VieCure on LinkedIn, Facebook, Twitter, Instagram and YouTube.

About Dr. Don Iverson

While a man of global impact, Dr. Iverson had strong ties to Colorado and was very involved in the health of the community. His time in Colorado left a significant impact that lasted after his passing in 2016 and will continue to last for generations to come. He earned a BSc from the University of North Dakota, and an MA and Ph.D. from the University of Oregon. He has published over 150 articles, book chapters and editorials on a variety of health-related topics. Her research interests included clinical, patient, and birthing issues in primary care medicine and health-related behavior change strategies.

Professor Iverson has held senior positions in government agencies (Associate Director of Cancer Control Science – US National Cancer Institute within the National Institutes of Health; Special Assistant – Office of Health Information, of Health Promotion, Fitness, and Sports Medicine at the Office of the U.S. Surgeon General); in non-governmental health organizations (Director of Behavioral Research and Program Evaluation – National Cancer Institute of Canada; Director of Cancer Control Research and Deputy Director – AMC Cancer Research Center) in business ( Chief Scientific Officer, OpTx Corporation) and in academia (Professor, Vice President for Research and Academic Affairs, Acting Chair – Department of Family Medicine, University of Colorado School of Medicine; Adjunct Professor – University of Denver Health Systems Research and Leadership Institute; Adjunct Professor – Department of Family Medicine, University of Toronto School of Medicine). He ended his career at the University of Wollongong (Australia) where he held several positions including Executive Dean of Health and Behavioral Sciences, Pro Vice Chancellor of Health, Executive Director of the Institute of Illawarra Medical and Health Research and Executive Dean of the Faculty of Science, Medicine and Health.

Comments are closed.